Page 33 - Dr Stephanie Seneff - Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID - 19
P. 33

CDC COVID-19 Response Team; Food and Drug Administration (2021, January 15). Allergic Reactions Including
                    Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine—United States, December
                    14–23, 2020. Morbidity and Mortality Weekly Report 70(2): 46.
                    https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm.
               CDC COVID-19 Response Team; Food and Drug Administration (2021, January 29). Allergic Reactions Including
                    Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine-United States. December 21, 2020 --
                    January 10, 2021. MMWR. Morbidity and Mortality Weekly Report 70(4): 125-129.
                    https://www.cdc.gov/mmwr/volumes/70/wr/mm7004e1.htm.
               Campos, J. Slon, L., Mongkolsapaya, J., & Screaton, G. R. (2018). The Immune Response Against Flaviviruses. Nature
                    immunology 19(11): 1189-1198. https://doi.org/10.1038/s41590-018-0210-3.
               Carsetti, R., Zaffina, S., Piano Mortari, E., Terreri, S., Corrente, F., Capponi, C., ... & Locatelli, F. (2020). Different
                    Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe
                    Cases. Frontiers in immunology, 11, 3365. https://www.frontiersin.org/articles/10.3389/fimmu.2020.610300/full
               Carter, M. J., Fish, M., Jennings, A., Doores, K. J., Wellman, P., Seow, J., … Shankar-Hari, M. (2020). Peripheral
                    Immunophenotypes in Children with Multisystem Inflammatory Syndrome Associated with SARS-CoV-2
                    Infection. Nature Medicine, 26(11), 1701-1707. https://doi.org/10.1038/s41591-020-1054-6.
               Centers for Disease Control and Prevention. COVID Data Tracker. https://covid.cdc.gov/covid-data-
                    tracker/#vaccinations. Accessed 2/6/21.

               Centers for Disease Control and Prevention, Prion Diseases. October 9, 2018. https://www.cdc.gov/prions/index.html.
               Centers for Disease Control and Prevention (1990). Vaccine Adverse Events Reporting System [database]. Retrieved
                    February 11, 2021 from https://vaers.hhs.gov/about.html

               Chen, W., Yang, B., Li, Z., Wang, P., Chen, Y. & Zhou, H. (2020). Sudden Severe Thrombocytopenia in a Patient in the
                    Recovery Stage of COVID-19. Lancet Haematology 7(8): e624. https://doi.org/10.1016/S2352-3026(20)30175-7.
               Cifuentes-Diaz, C., Delaporte, C., Dautréaux,B., Charron, D. & Fardeau, M. (1992) Class II MHC Antigens in Normal
                    Human Skeletal Muscle. Muscle Nerve 15(3): 295-302. https://doi.org/10.1002/mus.880150307.
               Classen, J. B. (2021). Review of COVID-19 Vaccines and the Risk of Chronic Adverse Events Including Neurological
                    Degeneration. Journal of Medical-Clinical Research and Reviews 5(4): 1-7.
                    https://foundationforhealthresearch.org/review-of-covid-19-vaccines- and-the-risk-of-chronic-adverse-events/.
               Corbett, K. S., Edwards, D.K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A. ... Graham, B. S. (2020)
                    SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness. Nature 586(7830): 567-571.
                    https://doi.org/10.1038/s41586-020-2622-0.
               Danielsson, R. & Eriksson, H. (2021, January 7). Aluminium Adjuvants in Vaccines -- A Way to Modulate the Immune
                    Response. Seminars in Cell & Developmental Biology. (Epub ahead of print)
                    https://doi.org/10.1016/j.semcdb.2020.12.008.
               Decock, M, Stanga, S., Octave, J.-N., Dewachter, I., Smith, S. O., Constantinescu, S. N., and Kienlen-Campard, P.
                    (2016). Glycines from the APP GXXXG/GXXXA Trans- membrane Motifs Promote Formation of Pathogenic A
                    Oligomers in Cells. Frontiers in Aging Neuroscience 8: 107. https://doi.org/10.3389/fnagi.2016.00107.
               Dicks, M. D. J., Spencer, A. J., Edwards, N. J., Wadell, G., Bojang, %K., Gilbert, S.C., ... Cottingham, M. G. (2012). A
                    Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector
                    Derivation and Comparative Immunogenicity. PLoS ONE 7(7): e40385.
                    https://doi.org/10.1371/journal.pone.0040385.
               Doshi, P. (2020). Will COVID-19 Vaccines Save Lives? Current Trials Aren't Designed to Tell Us. BMJ 371: m4037.
                    https://doi.org/10.1136/bmj.m4037.
               Doshi, P. (2021a). Peter Doshi: Pfizer and Moderna's “95% effective” vaccines—we need more details and the raw data.
                    BMJ blog. Accessed 02/20/2021. https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-
                    effective-vaccines-we-need-more-details-and-the-raw-data/


                              International Journal of Vaccine Theory, Practice, and Research 2(1), May 10, 2021 Page | 421
   28   29   30   31   32   33   34   35   36   37   38